Clinical review: Early treatment of acute lung injury - paradigm shift toward prevention and treatment prior to respiratory failure

Critical Care

Volumn 16, Issue 3, 2012, Pages

  Levitt, Joseph E ^a   Matthay, Michael A ^b  

^a STANFORD UNIVERSITY   (United States)

^b UCSF Medical Center at Parnassus   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ACETYLCYSTEINE; ACETYLSALICYLIC ACID; ACTIVATED PROTEIN C; ANGIOTENSIN RECEPTOR ANTAGONIST; BETA 2 ADRENERGIC RECEPTOR STIMULATING AGENT; BUDESONIDE; CORTICOSTEROID; DIPEPTIDYL CARBOXYPEPTIDASE INHIBITOR; HYDROXYMETHYLGLUTARYL COENZYME A REDUCTASE INHIBITOR; METHYLPREDNISOLONE; ROSUVASTATIN; SALBUTAMOL; SIMVASTATIN; TERBUTALINE; VITAMIN D; NONSTEROID ANTIINFLAMMATORY AGENT;

ACUTE LUNG INJURY; ADULT RESPIRATORY DISTRESS SYNDROME; ARTIFICIAL VENTILATION; CLINICAL TRIAL (TOPIC); CRITICAL ILLNESS; DISEASE SEVERITY; DRUG EFFICACY; HIGH RISK PATIENT; HUMAN; HYPOXEMIA; INTUBATION; LUNG COMPLIANCE; LUNG FUNCTION; LUNG MECHANICS; MORBIDITY; MORTALITY; MYOPATHY; NONHUMAN; NONINVASIVE VENTILATION; PHASE 2 CLINICAL TRIAL (TOPIC); PHASE 3 CLINICAL TRIAL (TOPIC); PRIORITY JOURNAL; RESPIRATORY FAILURE; REVIEW; RISK FACTOR; SURVIVAL; THERAPY DELAY; TIDAL VOLUME; TREATMENT INDICATION; TREATMENT OUTCOME; COMPLICATION; DISEASE COURSE; INTENSIVE CARE; RESPIRATORY INSUFFICIENCY; TIME FACTOR;

ACUTE LUNG INJURY; ADRENAL CORTEX HORMONES; ADRENERGIC BETA-2 RECEPTOR AGONISTS; ANTI-INFLAMMATORY AGENTS, NON-STEROIDAL; ASPIRIN; CRITICAL CARE; DISEASE PROGRESSION; HUMANS; HYDROXYMETHYLGLUTARYL-COA REDUCTASE INHIBITORS; RESPIRATION, ARTIFICIAL; RESPIRATORY INSUFFICIENCY; RISK FACTORS; TIME FACTORS;

EID: 84862487819     PISSN: 13648535     EISSN: 1466609X     Source Type: Journal    
DOI: 10.1186/cc11144     Document Type: Review

References (93)

1. Bernard G R, Artigas A, Brigham KL, Carlet J, Falke K, Hudson L, Lamy M, LeGall JR, Morris A, Spragg R. Report of the American-European Consensus conference on acute respiratory distress syndrome: definitions, mechanisms, relevant outcomes, and clinical trial coordination. Consensus Committee. J Crit Care 1994, 9:72-81. 10.1016/0883-9441(94)90033-7, 8199655.
2. Matthay MA, Zimmerman GA. Acute lung injury and the acute respiratory distress syndrome: four decades of inquiry into pathogenesis and rational management. Am J Resp Cell Mol Biol 2005, 33:319-327.
3. Rubenfeld GD, Caldwell E, Peabody E, Weaver J, Martin DP, Neff M, Stern EJ, Hudson LD. Incidence and outcomes of acute lung injury. N Engl J Med 2005, 353:1685-1693. 10.1056/NEJMoa050333, 16236739.
4. Ventilation with lower tidal volumes as compared with traditional tidal volumes for acute lung injury and the acute respiratory distress syndrome. The Acute Respiratory Distress Syndrome Network. N Engl J Med 2000, 342:1301-1308.
5. Brower RG, Lanken PN, MacIntyre N, Matthay MA, Morris A, Ancukiewicz M, Schoenfeld D, Thompson BT. Higher versus lower positive end-expiratory pressures in patients with the acute respiratory distress syndrome. N Engl J Med 2004, 351:327-336.
6. Meade MO, Cook DJ, Guyatt GH, Slutsky AS, Arabi YM, Cooper DJ, Davies AR, Hand LE, Zhou Q, Thabane L, Austin P, Lapinsky S, Baxter A, Russell J, Skrobik Y, Ronco JJ, Stewart TE, . Lung Open Ventilation Study Investigators Ventilation strategy using low tidal volumes, recruitment maneuvers, and high positive end-expiratory pressure for acute lung injury and acute respiratory distress syndrome: a randomized controlled trial. JAMA 2008, 299:637-645. 10.1001/jama.299.6.637, 18270352, Lung Open Ventilation Study Investigators.
7. Taccone P, Pesenti A, Latini R, Polli F, Vagginelli F, Mietto C, Caspani L, Raimondi F, Bordone G, Iapichino G, Mancebo J, Guérin C, Ayzac L, Blanch L, Fumagalli R, Tognoni G, Gattinoni L, . Prone-Supine II Study Group Prone positioning in patients with moderate and severe acute respiratory distress syndrome: a randomized controlled trial. JAMA 2009, 302:1977-1984. 10.1001/jama.2009.1614, 19903918, Prone-Supine II Study Group.
8. Calfee CS, Matthay MA. Nonventilatory treatments for acute lung injury and ARDS. Chest 2007, 131:913-920. 10.1378/chest.06-1743, 2789489, 17356114.
9. Levitt JE, Matthay MA. Treatment of acute lung injury: historical perspective and potential future therapies. Semin Respir Crit Care Med 2006, 27:426-437. 10.1055/s-2006-948296, 16909376.
10. Rivers E, Nguyen B, Havstad S, Ressler J, Muzzin A, Knoblich B, Peterson E, Tomlanovich M. Early goal-directed therapy in the treatment of severe sepsis and septic shock. N Engl J Med 2001, 345:1368-1377. 10.1056/NEJMoa010307, 11794169.
11. Ferguson ND, Frutos-Vivar F, Esteban A, Gordo F, Honrubia T, Penuelas O, Algora A, Garcia G, Bustos A, Rodriguez I. Clinical risk conditions for acute lung injury in the intensive care unit and hospital ward: a prospective observational study. Crit Care 2007, 11:R96. 10.1186/cc6113, 2556739, 17784960.
12. Flori HR, Glidden DV, Rutherford GW, Matthay MA. Pediatric acute lung injury: prospective evaluation of risk factors associated with mortality. Am J Respir Crit Care Med 2005, 171:995-1001. 10.1164/rccm.200404-544OC, 15618461.
13. Freishtat RJ, Mojgani B, Mathison DJ, Chamberlain JM. Toward early identification of acute lung injury in the emergency department. J Investig Med 2007, 55:423-429. 10.2310/6650.2007.00026, 2214900, 18163968.
14. Quartin AA, Campos MA, Maldonado DA, Ashkin D, Cely CM, Schein RM. Acute lung injury outside of the ICU: incidence in respiratory isolation on a general ward. Chest 2009, 135:261-268. 10.1378/chest.08-0280, 18689600.
15. Levitt JE, Bedi H, Calfee CS, Gould MK, Matthay MA. Identification of early acute lung injury at initial evaluation in an acute care setting prior to the onset of respiratory failure. Chest 2009, 135:936-943. 10.1378/chest.08-2346, 2758305, 19188549.
16. Gajic O, Dabbagh O, Park PK, Adesanya A, Chang SY, Hou P, Anderson H, Hoth JJ, Mikkelsen ME, Gentile NT, Gong MN, Talmor D, Bajwa E, Watkins TR, Festic E, Yilmaz M, Iscimen R, Kaufman DA, Esper AM, Sadikot R, Douglas I, Sevransky J, Malinchoc M, , . US Critical Illness and Injury Trials Group, Lung Injury Prevention Study Investigators (USCIITG-LIPS) Early identification of patients at risk of acute lung injury: evaluation of lung injury prediction score in a multicenter cohort study. Am J Respir Crit Care Med 2011, 183:462-470. 10.1164/rccm.201004-0549OC, 3056224, 20802164, US Critical Illness and Injury Trials Group, Lung Injury Prevention Study Investigators (USCIITG-LIPS).
17. Pepe PE, Potkin RT, Reus DH, Hudson LD, Carrico CJ. Clinical predictors of the adult respiratory distress syndrome. Am J Surg 1982, 144:124-130. 10.1016/0002-9610(82)90612-2, 7091520.
18. Herasevic h V, Yilmaz M, Khan H, Hubmayr RD, Gajic O. Validation of an electronic surveillance system for acute lung injury. Intensive Care Med 2009, 35:1018-1023. 10.1007/s00134-009-1460-1, 2730460, 19280175.
19. Herasevic h V, Tsapenko M, Kojicic M, Ahmed A, Kashyap R, Venkata C, Shahjehan K, Thakur SJ, Pickering BW, Zhang J, Hubmayr RD, Gajic O. Limiting ventilator-induced lung injury through individual electronic medical record surveillance. Crit Care Med 2011, 39:34-39. 10.1097/CCM.0b013e3181fa4184, 20959788.
20. Iscimen R, Cartin-Ceba R, Yilmaz M, Khan H, Hubmayr RD, Afessa B, Gajic O. Risk factors for the development of acute lung injury in patients with septic shock: an observational cohort study. Crit Care Med 2008, 36:1518-1522. 10.1097/CCM.0b013e31816fc2c0, 18434908.
21. Park PK, Birkmeyer NO, Gentile N, Chang SY, Dabbagh O, Gajic O. Early cumulative fluid balance and development of acute lung injury. Am J Respir Crit Care Med 2011, 183:A5592.
22. Silliman CC. The two-event model of transfusion-related acute lung injury. Crit Care Med 2006, 34(5 Suppl):S124-131.
23. Looney MR, Nguyen JX, Hu Y, Van Ziffle JA, Lowell CA, Matthay MA. Platelet depletion and aspirin treatment protect mice in a two-event model of transfusion-related acute lung injury. J Clin Invest 2009, 119:3450-3461. 2769181, 19809160.
24. Looney MR, Su X, Van Ziffle JA, Lowell CA, Matthay MA. Neutrophils and their Fc gamma receptors are essential in a mouse model of transfusion-related acute lung injury. J Clin Invest 2006, 116:1615-1623. 10.1172/JCI27238, 1462945, 16710475.
25. Bux J, Sachs UJ. The pathogenesis of transfusion-related acute lung injury (TRALI). Br J Haematol 2007, 136:788-799. 10.1111/j.1365-2141.2007.06492.x, 17341264.
26. Kleinman S, Caulfield T, Chan P, Davenport R, McFarland J, McPhedran S, Meade M, Morrison D, Pinsent T, Robillard P, Slinger P. Toward an understanding of transfusion-related acute lung injury: statement of a consensus panel. Transfusion 2004, 44:1774-1789. 10.1111/j.0041-1132.2004.04347.x, 15584994.
27. Toy P, Popovsky MA, Abraham E, Ambruso DR, Holness LG, Kopko PM, McFarland JG, Nathens AB, Silliman CC, Stroncek D. Transfusion-related acute lung injury: definition and review. Crit Care Med 2005, 33:721-726. 10.1097/01.CCM.0000159849.94750.51, 15818095.
28. Popovsky MA, Abel MD, Moore SB. Transfusion-related acute lung injury associated with passive transfer of antileukocyte antibodies. Am Rev Respir Dis 1983, 128:185-189.
29. Popovsky MA, Moore SB. Diagnostic and pathogenetic considerations in transfusion-related acute lung injury. Transfusion 1985, 25:573-577. 10.1046/j.1537-2995.1985.25686071434.x, 4071603.
30. Gajic O, Rana R, Winters JL, Yilmaz M, Mendez JL, Rickman OB, O'Byrne MM, Evenson LK, Malinchoc M, DeGoey SR, Afessa B, Hubmayr RD, Moore SB. Transfusion-related acute lung injury in the critically ill: prospective nested case-control study. Am J Respir Crit Care Med 2007, 176:886-891. 10.1164/rccm.200702-271OC, 2048675, 17626910.
31. Marik PE, Corwin HL. Acute lung injury following blood transfusion: expanding the definition. Crit Care Med 2008, 36:3080-3084. 10.1097/CCM.0b013e31818c3801, 18824899.
32. Chapman C E, Stainsby D, Jones H, Love E, Massey E, Win N, Navarrete C, Lucas G, Soni N, Morgan C, Choo L, Cohen H, Williamson LM, . Serious Hazards of Transfusion Steering Group Ten years of hemovigilance reports of transfusion-related acute lung injury in the United Kingdom and the impact of preferential use of male donor plasma. Transfusion 2009, 49:440-452. 10.1111/j.1537-2995.2008.01948.x, 18980623, Serious Hazards of Transfusion Steering Group.
33. Eder AF, Herron RM, Strupp A, Dy B, White J, Notari EP, Dodd RY, Benjamin RJ. Effective reduction of transfusion-related acute lung injury risk with male-predominant plasma strategy in the American Red Cross (2006-2008). Transfusion 2010, 50:1732-1742. 10.1111/j.1537-2995.2010.02652.x, 20456698.
34. Gajic O, Dara SI, Mendez JL, Adesanya AO, Festic E, Caples SM, Rana R, St Sauver JL, Lymp JF, Afessa B, Hubmayr RD. Ventilator-associated lung injury in patients without acute lung injury at the onset of mechanical ventilation. Crit Care Med 2004, 32:1817-1824. 10.1097/01.CCM.0000133019.52531.30, 15343007.
35. Determann RM, Royakkers A, Wolthuis EK, Vlaar AP, Choi G, Paulus F, Hofstra JJ, de Graaff MJ, Korevaar JC, Schultz MJ. Ventilation with lower tidal volumes as compared with conventional tidal volumes for patients without acute lung injury: a preventive randomized controlled trial. Crit Care 2010, 14:R1. 10.1186/cc8230, 2875503, 20055989.
36. Hilbert G, Gruson D, Vargas F, Valentino R, Gbikpi-Benissan G, Dupon M, Reiffers J, Cardinaud JP. Noninvasive ventilation in immunosuppressed patients with pulmonary infiltrates, fever, and acute respiratory failure. N Engl J Med 2001, 344:481-487. 10.1056/NEJM200102153440703, 11172189.
37. Ferrer M, Esquinas A, Leon M, Gonzalez G, Alarcon A, Torres A. Noninvasive ventilation in severe hypoxemic respiratory failure: a randomized clinical trial. Am J Respir Crit Care Med 2003, 168:1438-1444. 10.1164/rccm.200301-072OC, 14500259.
38. Delclaux C, L'Her E, Alberti C, Mancebo J, Abroug F, Conti G, Guérin C, Schortgen F, Lefort Y, Antonelli M, Lepage E, Lemaire F, Brochard L. Treatment of acute hypoxemic nonhypercapnic respiratory insufficiency with continuous positive airway pressure delivered by a face mask: A randomized controlled trial. JAMA 2000, 284:2352-2360. 10.1001/jama.284.18.2352, 11066186.
39. Antonelli M, Conti G, Esquinas A, Montini L, Maggiore SM, Bello G, Rocco M, Maviglia R, Pennisi MA, Gonzalez-Diaz G, Meduri GU. A multiple-center survey on the use in clinical practice of noninvasive ventilation as a firstline intervention for acute respiratory distress syndrome. Crit Care Med 2007, 35:18-25. 10.1097/01.CCM.0000251821.44259.F3, 17133177.
40. Rana S, Je nad H, Gay PC, Buck CF, Hubmayr RD, Gajic O. Failure of noninvasive ventilation in patients with acute lung injury: observational cohort study. Crit Care 2006, 10:R79. 10.1186/cc4923, 1550938, 16696863.
41. Li G, Mali nchoc M, Cartin-Ceba R, Venkata CV, Kor DJ, Peters SG, Hubmayr RD, Gajic O. Eight-year trend of acute respiratory distress syndrome: a population-based study in Olmsted County, Minnesota. Am J Respir Crit Care Med 2011, 183:59-66. 10.1164/rccm.201003-0436OC, 3040394, 20693377.
42. Ciesla DJ, Moore EE, Johnson JL, Cothren CC, Banerjee A, Burch JM, Sauaia A. Decreased progression of postinjury lung dysfunction to the acute respiratory distress syndrome and multiple organ failure. Surgery 2006, 140:640-647. discussion 647-648, 10.1016/j.surg.2006.06.015, 17011912.
43. Looney MR, Gropper MA, Matthay MA. Transfusion-related acute lung injury: a review. Chest 2004, 126:249-258. 10.1378/chest.126.1.249, 15249468.
44. Erlich JM, Talmor DS, Cartin-Ceba R, Gajic O, Kor DJ. Prehospitalization antiplatelet therapy is associated with a reduced incidence of acute lung injury: a population-based cohort study. Chest 2011, 139:289-295. 10.1378/chest.10-0891, 3032365, 20688925.
45. Kor DJ, Erlich J, Gong MN, Malinchoc M, Carter RE, Gajic O, Talmor D. Pre-hospital aspirin therapy and development of acute lung injury: a secondary analysis of the US Critical Illness And Injury Trials Group Lung Injury Prevention Study. Am J Respir Crit Care Med 2011, 183:A6344.
46. Merx MW, Liehn EA, Janssens U, Lutticken R, Schrader J, Hanrath P, Weber C. HMG-CoA reductase inhibitor simvastatin profoundly improves survival in a murine model of sepsis. Circulation 2004, 109:2560-2565. 10.1161/01.CIR.0000129774.09737.5B, 15123521.
47. Pruefer D, Makowski J, Schnell M, Buerke U, Dahm M, Oelert H, Sibelius U, Grandel U, Grimminger F, Seeger W, Meyer J, Darius H, Buerke M. Simvastatin inhibits inflammatory properties of Staphylococcus aureus alpha-toxin. Circulation 2002, 106:2104-2110. 10.1161/01.CIR.0000034048.38910.91, 12379581.
48. Ando H, Takamura T, Ota T, Nagai Y, Kobayashi K. Cerivastatin improves survival of mice with lipopolysaccharide-induced sepsis. J Pharmacol Exp Ther 2000, 294:1043-1046.
49. Jacobson JR, Barnard JW, Grigoryev DN, Ma SF, Tuder RM, Garcia JG. Simvastatin attenuates vascular leak and inflammation in murine inflammatory lung injury. Am J Physiol Lung Cell Mol Physiol 2005, 288:L1026-1032.
50. Pirat A, Zeyneloglu P, Aldemir D, Yucel M, Ozen O, Candan S, Arslan G. Pretreatment with simvastatin reduces lung injury related to intestinal ischemia-reperfusion in rats. Anesth Analg 2006, 102:225-232. 10.1213/01.ane.0000189554.41095.98, 16368834.
51. Merx MW, Liehn EA, Graf J, van de Sandt A, Schaltenbrand M, Schrader J, Hanrath P, Weber C. Statin treatment after onset of sepsis in a murine model improves survival. Circulation 2005, 112:117-124. 10.1161/CIRCULATIONAHA.104.502195, 15998696.
52. Karaca I, Ilkay E, Akbulut M, Yavuzkir M, Pekdemir M, Akbulut H, Arslan N. Atorvastatin affects C-reactive protein levels in patients with coronary artery disease. Curr Med Res Opin 2003, 19:187-191. 10.1185/030079903125001686, 12803732.
53. Kinlay S, Schwartz GG, Olsson AG, Rifai N, Leslie SJ, Sasiela WJ, Szarek M, Libby P, Ganz P. High-dose atorvastatin enhances the decline in inflamatory markers in patients with acute coronary syndromes in the MIRACL study. Circulation 2003, 108:1560-1566. 10.1161/01.CIR.0000091404.09558.AF, 12975259.
54. Laufs U, Wassmann S, Hilgers S, Ribaudo N, Bohm M, Nickenig G. Rapid effects on vascular function after initiation and withdrawal of atorvastatin in healthy, normocholesterolemic men. Am J Cardiol 2001, 88:1306-1307. 10.1016/S0002-9149(01)02095-1, 11728362.
55. van de Ree MA, Huisman MV, Princen HM, Mein ders AE, Kluft C. Strong decrease of high sensitivity C-reactive protein with high-dose atorvastatin in patients with type 2 diabetes mellitus. Atherosclerosis 2003, 166:129-135. 10.1016/S0021-9150(02)00316-7, 12482559.
56. Acute lung injury and the acute respiratory distress syndrome in Ireland: a prospective audit of epidemiology and management. Crit Care 2008, 12:R30. 10.1186/cc6808, 2374618, 18312626.
57. Almog Y, Shefer A, Novack V, Maimon N, Bars ki L, Eizinger M, Friger M, Zeller L, Danon A. Prior statin therapy is associated with a decreased rate of severe sepsis. Circulation 2004, 110:880-885. 10.1161/01.CIR.0000138932.17956.F1, 15289367.
58. Donnino MW, Cocchi MN, Howell M, Clardy P, Talmor D, Cataldo L, Chase M, Al-Marshad A, Ngo L, Shapiro NI. Statin therapy is associated with decreased mortality in patients with infection. Acad Emerg Med 2009, 16:230-234. 10.1111/j.1553-2712.2009.00350.x, 19281494.
59. Kruger P, Fitzsimmons K, Cook D, Jones M, Nimmo G. Statin therapy is associated with fewer deaths in patients with bacteraemia. Intensive Care Med 2006, 32:75-79. 10.1007/s00134-005-2859-y, 16283159.
60. Liappis AP, Kan VL, Rochester CG, Simon GL. The effect of statins on mortality in patients with bacteremia. Clin Infect Dis 2001, 33:1352-1357. 10.1086/323334, 11565076.
61. Chalmers JD, Singanayagam A, Murray MP, Hil l AT. Prior statin use is associated with improved outcomes in community-acquired pneumonia. Am J Med 2008, 121:1002-1007 e1001. 10.1016/j.amjmed.2008.06.030, 18954848.
62. Thomsen RW, Riis A, Kornum JB, Christensen S, Johnsen SP, Sorensen HT. Preadmission use of statins and outcomes after hospitalization with pneumonia: population-based cohort study of 29,900 patients. Arch Intern Med 2008, 168:2081-2087. 10.1001/archinte.168.19.2081, 18955636.
63. O'Neal HR, Koyama T, Koehler EA, Siew E, Curtis BR, Fremont RD, May AK, Bernard GR, Ware LB. Prehospital statin and aspirin use and the prevalence of severe sepsis and acute lung injury/acute respiratory distress syndrome. Crit Care Med 2011, 39:1343-1350. 10.1097/CCM.0b013e3182120992, 3102130, 21336116.
64. Craig TR, Duffy MJ, Shyamsundar M, McDowell C, O'Kane CM, Elborn JS, McAuley DF. A randomized clinical trial of hydroxymethylglutaryl-coenzyme a reductase inhibition for acute lung injury (The HARP Study). Am J Respir Crit Care Med 2011, 183:620-626. 10.1164/rccm.201003-0423OC, 20870757.
65. Matthay MA, Folkesson HG, Clerici C. Lung e pithelial fluid transport and the resolution of pulmonary edema. Physiol Rev 2002, 82:569-600.
66. Khimenko PL, Barnard JW, Moore TM, Wilson P S, Ballard ST, Taylor AE. Vascular permeability and epithelial transport effects on lung edema formation in ischemia and reperfusion. J Appl Physiol 1994, 77:1116-1121.
67. McAuley DF, Frank JA, Fang X, Matthay MA. Clinically relevant concentrations of beta2-adrenergic agonists stimulate maximal cyclic adenosine monophosphate-dependent airspace fluid clearance and decrease pulmonary edema in experimental acid-induced lung injury. Crit Care Med 2004, 32:1470-1476. 10.1097/01.CCM.0000129489.34416.0E, 15241090.
68. Maris NA, de Vos AF, Dessing MC, Spek CA, Lutter R, Jansen HM, van der Zee JS, Bresser P, van der Poll T. Antiinflammatory effects of salmeterol after inhalation of lipopolysaccharide by healthy volunteers. Am J Respir Crit Care Med 2005, 172:878-884. 10.1164/rccm.200503-451OC, 15994467.
69. Atabai K, Ware LB, Snider ME, Koch P, Danie l B, Nuckton TJ, Matthay MA. Aerosolized beta(2)-adrenergic agonists achieve therapeutic levels in the pulmonary edema fluid of ventilated patients with acute respiratory failure. Intensive Care Med 2002, 28:705-711. 10.1007/s00134-002-1282-x, 12107675.
70. Manocha S, Gordon AC, Salehifar E, Groshaus H, Walley KR, Russell JA. Inhaled beta-2 agonist salbutamol and acute lung injury: an association with improvement in acute lung injury. Crit Care 2006, 10:R12. 10.1186/cc3971, 1550825, 16420663.
71. Perkins GD, McAuley DF, Thickett DR, Gao F. The beta-agonist lung injury trial (BALTI): a randomized placebo-controlled clinical trial. Am J Respir Crit Care Med 2006, 173:281-287. 10.1164/rccm.200508-1302OC, 16254268.
72. Matthay MA, Brower RG, Carson S, Douglas IS, Eisner M, Hite D, Holets S, Kallet RH, Liu KD, MacIntyre N, Moss M, Schoenfeld D, Steingrub J, Thompson BT. National Heart and Blood Institute Acute Respiratory Distress Syndrome (ARDS) Clinical Trials Network Randomized, placebo-controlled clinical trial of an aerosolized beta-2 agonist for treatment of acute lung injury. Am J Respir Crit Care Med 2011, 184:561-568. National Heart and Blood Institute Acute Respiratory Distress Syndrome (ARDS) Clinical Trials Network.
73. Smith FG, Perkins GD, Gates S, Young D, McAuley DF, Tunnicliffe W, Khan Z, Lamb SE. Effect of intravenous beta-2 agonist treatment on clinical outcomes in acute respiratory distress syndrome (BALTI-2): a multicentre, randomised controlled trial. Lancet 2011, 379:229-235. 3266479, 22166903.
74. Ware LB, Matthay MA. Alveolar fluid clearance is impaired in the majority of patients with acute lung injury and the acute respiratory distress syndrome. Am J Respir Crit Care Med 2001, 163:1376-1383.
75. Wiedemann HP, Wheeler AP, Bernard GR, Thomp son BT, Hayden D, deBoisblanc B, Connors AF, Hite RD, Harabin AL. Comparison of two fluidmanagement strategies in acute lung injury. N Engl J Med 2006, 354:2564-2575.
76. Meduri GU, Headley AS, Golden E, Carson SJ, Umberger RA, Kelso T, Tolley EA. Effect of prolonged methylprednisolone therapy in unresolving acute respiratory distress syndrome: a randomized controlled trial. JAMA 1998, 280:159-165. 10.1001/jama.280.2.159, 9669790.
77. Steinberg KP, Hudson LD, Goodman RB, Hough CL, Lanken PN, Hyzy R, Thompson BT, Ancukiewicz M, . National Heart and Blood Institute Acute Respiratory Distress Syndrome (ARDS) Clinical Trials Network Efficacy and safety of corticosteroids for persistent acute respiratory distress syndrome. N Engl J Med 2006, 354:1671-1684. National Heart and Blood Institute Acute Respiratory Distress Syndrome (ARDS) Clinical Trials Network.
78. Walther S, Jansson I, Berg S, Lennquist S. Pulmonary granulocyte accumulation is reduced by nebulized corticosteroid in septic pigs. Acta Anaesthesiol Scand 1992, 36:651-655. 10.1111/j.1399-6576.1992.tb03537.x, 1441865.
79. Walther S, Jansson I, Berg S, Olsson Rex L, Lennquist S. Corticosteroid by aerosol in septic pigs - effects on pulmonary function and oxygen transport. Intensive Care Med 1993, 19:155-160. 10.1007/BF01720531, 8315123.
80. Forsgren PE, Modig JA, Dahlback CM, Axelsson BI. Prophylactic treatment with an aerosolized corticosteroid liposome in a porcine model of early ARDS induced by endotoxaemia. Acta Chir Scand 1990, 156:423-431.
81. Wang J, Zhang L, Walther SM. Administration of aerosolized terbutaline and budesonide reduces chlorine gas-induced acute lung injury. J Trauma 2004, 56:850-862. 10.1097/01.TA.0000078689.45384.8B, 15187753.
82. Jansson AH, Eriksson C, Wang X. Effects of budesonide and N-acetylcysteine on acute lung hyperinflation, inflammation and injury in rats. Vascul Pharmacol 2005, 43:101-111. 10.1016/j.vph.2005.03.006, 15967733.
83. Enrique O-D, Guangxi L, Daryl K, Ognjen G, Ozan A, Adebola A, Jason H, Festic A. Preadmission use of inhaled corticosteroids is associated with a reduced risk of direct acute lung injury/acute respiratory distress syndrome. Chest 2011, 140:912A.
84. Hagiwara S, Iwasaka H, Hidaka S, Hasegawa A, Koga H, Noguchi T. Antagonist of the type-1 ANG II receptor prevents against LPS-induced septic shock in rats. Intensive Care Med 2009, 35:1471-1478. 10.1007/s00134-009-1545-x, 19529910.
85. Hagiwara S, Iwasaka H, Matumoto S, Hidaka S, Noguchi T. Effects of an angiotensin-converting enzyme inhibitor on the inflammatory response in in vivo and in vitro models. Crit Care Med 2009, 37:626-633. 10.1097/CCM.0b013e3181958d91, 19114890.
86. Watkins TR, Lemos-Filho LB, Dabbagh O, Chan g SY, Park PK, Gong MN. Use Of angiotensin converting enzyme inhibitors or angiotensin receptor blockers and clinical outcomes among patients at-risk for acute lung injury. Am J Respir Crit Care Med 2011, 183:A5598.
87. Hughes DA, Norton R. Vitamin D and respiratory health. Clin Exp Immunol 2009, 158:20-25. 10.1111/j.1365-2249.2009.04001.x, 2759054, 19737226.
88. Jeng L, Yamshchikov AV, Judd SE, Blumberg H M, Martin GS, Ziegler TR, Tangpricha V. Alterations in vitamin D status and anti-microbial peptide levels in patients in the intensive care unit with sepsis. J Transl Med 2009, 7:28. 10.1186/1479-5876-7-28, 2684740, 19389235.
89. Lucidarme O, Messai E, Mazzoni T, Arcade M, du Cheyron D. Incidence and risk factors of vitamin D deficiency in critically ill patients: results from a prospective observational study. Intensive Care Med 2010, 36:1609-1611. 10.1007/s00134-010-1875-8, 20373095.
90. Barnett N, Koyama T, Janz DR, May AK, Berna rd GR, Ware LB. Vitamin D deficiency does not modulate the risk of acute lung injury: a case control study. Am J Respir Crit Care Med 2011, 183:A5596.
91. Ware LB, Matthay MA, Parsons PE, Thompson B T, Januzzi JL, Eisner MD. Pathogenetic and prognostic significance of altered coagulation and fibrinolysis in acute lung injury/acute respiratory distress syndrome. Crit Care Med 2007, 35:1821-1828. 10.1097/01.CCM.0000221922.08878.49, 2764536, 17667242.
92. Liu KD, Levitt J, Zhuo H, Kallet RH, Brady S, Steingrub J, Tidswell M, Siegel MD, Soto G, Peterson MW, Chesnutt MS, Phillips C, Weinacker A, Thompson BT, Eisner MD, Matthay MA. Randomized clinical trial of activated protein C for the treatment of acute lung injury. Am J Respir Crit Care Med 2008, 178:618-623. 10.1164/rccm.200803-419OC, 2542435, 18565951.
93. Clip. , https://ephpublic.aecom.yu.edu/clip